Carlos Alberto de Oliveira Andrade Medicine to Business

Former physician Carlos Alberto de Oliveira Andrade has transferred his medical expertise to the art of selling vehicles. Now Chairman of CAOA, a Brazilian carmaker/distributor, Dr. Carlos has the distinction of 1,000,000 vehicle sales. Born in João Pessoa, the capital of the State of Paraíba (PB) in Brazil, Dr. Carlos began a medical career reaching the North and Northeast of Brazil. His ownership of CAOA began in an unusual way. While practicing medicine, he bought a Ford Landau from a Campina Grande (PB) dealership which declared bankruptcy before delivery. As a condition of sale, Dr. Carlos negotiated the acquisition of the dealership in lieu of the vehicle. It worked. CAOA was created and was soon the leading Ford dealership in Brazil. Its initials stand for its founders name: Carlos Alberto de Oliveira Andrade.

By 1992, CAOA was the official Brazilian importer of the French Renault though a few years later Renault obviated the import agreement. By 1998, CAOA was designated official importer for Subaru and tripled national Subaru sales. Dr. Carlos then acquired the Hyundai brand, Tucson model, which led Brazil’s imported cars sector. By 2007, CAOA Automobile S/A, Goiás, was built to manufacture Hyundai vehicles, and became the first Brazilian Hyundai automobile factory.

Several personal and business accolades followed.

  • Recognized as 2007 “Entrepreneur of the Year in Industry” by IstoÉ Dinheiro Magazine
  • Recognized as “Good Doer Company” by IstoÉ Dinheiro
  • Recognized as “Distributor of the Year” by Hyundai’s parent company
  • CAOA Plant Recognized as the “Most Admired” company by the weekly magazine Carta Capital

JD Power Institute ranked CAOA #1 in pre/post sales both in 2014 and 2017. Dr. Carlos has most recently partnered with Chery to create CAOA CHERY, a new Brazilian-based auto manufacturer. After 40 years in the automobile business, Carlos Alberto de Oliveira Andrade continues manufacturing position viability for Brazil.

Discover more:

Comments are closed.